 |
|
|
|
|
|
|
| Article 1 to 10 out of 15 concerning Affymetrix Inc.
|
-
Roche NimbleGen and Affymetrix Expand Licensing Agreement
(17 Mar 2008)
Roche NimbleGen Inc., a company of Roche Applied Science, and Affymetrix Inc. announced that they have expanded the terms of the license to a number of Affymetrix patents originally granted in October 2006. The expanded license now provides certain ...
-
Affymetrix and Empire Genomics Enter Into Licensing Agreement
(11 Sep 2007)
Affymetrix Inc. announced that Empire Genomics, LLC, has obtained a non-exclusive, worldwide license to a number of Affymetrix patents covering the manufacturing, use and sales of nucleic acid microarrays and related products and services for ...
-
Affymetrix Launches Program to Advance Cancer Research
(19 Apr 2007)
Partnership With Leading Scientists Aims to Accelerate Breakthroughs in More Than 10 Types of Cancers
Affymetrix Inc. announced the launch of the Collaborations in Cancer Research Program, an alliance between Affymetrix and up to 30 leading European cancer researchers. As part of the program, Affymetrix will partially fund selected research projects ...
-
Scan of Entire Human Genome Finds Unexpected New Clues on Lou Gehrig's Disease
(04 Dec 2006)
A comprehensive scan of the human genome has identified more than 50 genetic abnormalities in people with sporadic amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease), the Muscular Dystrophy Association (MDA) and the Translational Genomics ...
-
Affymetrix Appoints Masao Yoneyama as General Manager of Japan Operations
(16 Oct 2006)
Affymetrix Inc. announced that it has named Masao Yoneyama, Ph.D., General Manager of Japan Operations. As part of this role, Dr. Yoneyama has been elected as Affymetrix' representative director for Japan and will be responsible for growing the ...
-
Affymetrix Selected to Genotype More Than 9,000 Framingham Heart Study Samples
(07 Sep 2006)
SHARE Project to Help Identify Genetic Variants Associated With Heart, Lung, Blood and Sleep Disorders
Affymetrix Inc. announced that it has been selected by the SHARE (SNP Health Association REsource) project for a large-scale whole-genome association study. As part of the project, Affymetrix will collaborate with the National Heart, Lung, and Blood ...
-
Affymetrix Appoints Robert Trice to Board of Directors
(17 Feb 2006)
Affymetrix Inc. announced that Robert H. Trice, Ph.D., senior vice president for business development at Lockheed Martin Corporation and chairman and CEO of Lockheed Martin Global Inc., has been elected to the company's board of directors.Trice is ...
-
Affymetrix and Iconix Collaborate to Develop New Solutions for Assessing Drug Toxicity
(09 Feb 2006)
Affymetrix Inc. and Iconix Pharmaceuticals Inc. announced that the companies have signed a collaborative agreement to develop solutions to aid in the study of the toxicological and pharmacological properties of drugs and drug candidates. The ...
-
Duke University and Affymetrix Initiate Five-Year Translational Research Collaboration
(11 Jan 2006)
Affymetrix Inc. announced that it has entered into a five-year collaboration with Duke University to analyze genomic information across large patient samples. Under terms of the agreement, Duke researchers will use Affymetrix GeneChip(R) microarray ...
-
Affymetrix and Applied Biosystems Enter into Licensing Agreement
(27 Dec 2005)
Affymetrix, Inc. and Applied Biosystems Group, an Applera Corporation business, announced that Applera has taken a non-exclusive, worldwide license to a number of Affymetrix patents related to the manufacture, sale, and use of microarrays for gene ...
|
|
|
|
|
Top
analytica
analytica China
analytica Vietnam
analytica Anacon